Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 20 (79 total).

Minnesota Department of Health. 2021. Infant mortality in Minnesota . [St. Paul, MN]: Minnesota Department of Health, 7 pp.

Annotation: This report describes the landscape of infant mortality in Minnesota, addressing prematurity and birth defects, racial and ethnic disparities, racial justice, and statewide strategic planning to addresses health inequities and improve birth outcomes. A discussion of the COVID-19 pandemic and its impact on infant mortality is included.

Contact: U.S. Maternal and Child Health Bureau, Health Resources and Services Administration, 5600 Fishers Lane, Rockville, MD 20857, Telephone: (301) 443-2170 Web Site: https://mchb.hrsa.gov Available from the website.

Keywords: Alcohol use during pregnancy, Drug use during pregnancy, Ethnic factors, Infant death, Infant mortality, Minnesota, Prenatal influences, Racial factors, Risk factors, State initiatives

Association of Maternal and Child Health Programs . 2021. Perinatal cannabis use in the era of increasing legalization: Considerations for state MCH programs. Washington, DC: Association of Maternal and Child Health Programs , 28 pp.

Annotation: This issue brief is a call to action for maternal and child health (MCH) professionals to be leaders in designing and implementing public health approaches to minimize the potential harms of perinatal cannabis (marijuana) use. The brief describes trends in Cannabis use among pregnant people, addresses the changing policy landscape, and discusses the racial implications of criminalizing the use of drugs among pregnant people and mothers. State MCH program approaches to help prevent eprinatal cannabis use are included.

Contact: Association of Maternal and Child Health Programs, 1825 K Street, N.W., Suite 250, Washington, DC 20006-1202, Telephone: (202) 775-0436 Fax: (202) 478-5120 E-mail: [email protected] Web Site: http://www.amchp.org

Keywords: Cannabis, Illicit drugs, Marijuana, Maternal health, Models, Perinatal care, Pregnancy, Prevention, Substance use

Child Welfare Information Gateway. 2020. Bulletins for professionals: Preventing, identifying, and treating substance use among youth in foster care. Washington, DC: Child Welfare Information Gatewayu, 18 pp. (Bulletins for Professionals)

Annotation: Because youth in foster care have a higher propensity for drug use, this report was written to inform child welfare professionals, treatment providers, families, and community members on the signs of drug use and the risk factors that and impact of substance abuse. The report also provides links and information on various prevention and treatment initiatives, including those determined to be culturally sensitive.

Contact: Child Welfare Information Gateway, Administration on Children, Youth, and Families, Children's Bureau, 1250 Maryland Avenue, S.W., Eighth Floor, Washington, DC 20024, Telephone: (800) 394-3366 Secondary Telephone: E-mail: [email protected] Web Site: http://www.childwelfare.gov

Keywords: Alcohol abuse, Drug abuse, Drug affected children, Drug use behavior, Foster care, Foster children, Substance abuse prevention, Substance use disorders

U.S. Office of the Surgeon General. 2018. Surgeon General's advisory on e-cigarette use among youth. Rockville, MD: U.S. Office of the Surgeon General, 4 pp.

Annotation: This advisory warns of the e-cigarette epidemic among youth. The document explains the different types of e-cigarettes and offers information for parents, teachers, health professionals, and states, communities, tribes, and territories. There are links to relevant studies and publications.

Contact: U.S. Office of the Surgeon General, Tower Building, Plaza Level 1, Room 100, 1101 Wootton Parkway, Rockville, MD 20852, Telephone: (240) 276-8853 Fax: (240) 453-6141 Web Site: http://www.surgeongeneral.gov/index.html

Keywords: Adolescent health, Adolescents, Adverse effects, Disease prevention, Drug administration routes, Federal agencies, Nicotine, Prevention, Regulations, Risk factors, Smoking, Substance abuse, Substance use behaviors, Tobacco, Young adults

Ko HY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD. 2016. Incidence of neonatal abstinence syndrome: 28 states, 1999–2013. Morbidity and Mortality Weekly Report 65(31):799–802,

Annotation: This report examines state trends in neonatal abstinence syndrome (NAS) incidence using all-payer, hospital inpatient delivery discharges compiled in the State Inpatient Databases of the Healthcare Cost and Utilization Project (HCUP) during 1999–2013. The findings underscore the importance of state-based public health programs to prevent unnecessary opioid use and to treat substance use disorders during pregnancy, as well as decrease the incidence of NAS.

Contact: Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, Telephone: (800) 232-4636 Secondary Telephone: (888) 232-6348 E-mail: [email protected] Web Site: http://www.cdc.gov Available from the website.

Keywords: Drug use during pregnancy, Measures, Neonatal abstinence syndrome, Newborn infants, Opiates, Pregnant women, State programs, Statistical data, Substance use disorders, Trends

National Advisory Committee on Rural Health and Human Services. 2016. Families in crisis: The human services implications of rural opioid misuse. [Rockville, MD]: National Advisory Committee on Rural Health and Human Services, 9 pp.

Annotation: This policy brief discusses the unique rural challenges related to opioid use disorder and the experiences of families in crisis and recommendations for federal action. Topics include the opioid epidemic as a national problem with rural differentials, opioid abuse trends in rural communities, substance abuse and child welfare, the role of federal block grants, and barriers to treatment and services. Opportunities for creating a stronger treatment system for opioid use disorders are also addressed including the role of support services, care coordination and mental health workers to address current shortages in rural communities, increasing the availability of treatment programs, and research. A case study from Indiana is included.

Contact: National Advisory Committee on Rural Health and Human Services, Health Resources and Services Administration, Federal Office of Rural Health Policy, 5600 Fishers Lane, 17W59D, Rockville, MD 20857, Telephone: (301) 443-0835 Fax: (301) 443-2803 Web Site: http://www.hrsa.gov/advisorycommittees/rural/index.html Available from the website.

Keywords: Access to health care, Barriers, Child welfare, Crisis intervention, Drug addiction, Family support services, Federal initiatives, Health care systems, Health policy, Interagency cooperation, Mental health, Opiates, Policy development, Program coordination, Rural population, Service coordination, Substance abuse prevention programs, Substance abuse treatment services, Substance use disorders, Systems development, Work force

National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2016. Betel quid with tobacco (gutka). Atlanta, GA: Centers for Disease Control and Prevention, 1 p.

Annotation: This fact sheet provides information about the use and health effects of betel quid, a combination of betel leaf, areca nut, and slaked lime. Topics include betel quid and gutka (betel quid with tobacco) use by men and women and by region. Health issues associated with the use of betel quid and gutka such as precancerous conditions, cancer, reproductive health problems, and nicotine addiction are also discussed.

Contact: National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, Telephone: (800) 232-4636 Secondary Telephone: (888) 232-6348 Fax: E-mail: [email protected] Web Site: http://www.cdc.gov/tobacco Available from the website.

Keywords: Cancer, Drug effects, Nicotine, Oral health, Pregnant women, Preventive health services, Reproductive health, Risk factors, Smokeless tobacco, Tobacco use

Robers S, Zhang A, Morgan RE, Musu-Gillette L. 2015-. Indicators of school crime and safety: 20-. Washington, DC: National Center for Education Statistics and Bureau of Justice Statistics, annual.

Annotation: This annual report presents data on school crime and student safety. The indicators in the report are based on information drawn from a variety of data sources including national surveys of students, teachers, principals, and postsecondary institutions. The report covers topics such as victimization, teacher injury, bullying and cyberbullying, school conditions, fights, weapons, availability and student use of drugs and alcohol, student perceptions of personal safety at school, and criminal incidents at postsecondary institutions. Indicators of crime and safety are compared across different population subgroups and over time. Data on crimes that occur away from school are offered as a point of comparison where available.

Contact: National Center for Education Statistics, 1990 K Street, N. W., Washington, DC 20006, Telephone: (202) 502-7300 Secondary Telephone: (202) 502-7442 Fax: (202) 219-1736 Web Site: http://www.nces.ed.gov Available from the website.

Keywords: Bullying, College students, Colleges, Crime, Data, Drug use, Environmental influences, Injuries, School age children, School safety, Schools, Trends, Violence, Weapons

U.S. Government Accountability Office. 2015. Prenatal drug use and newborn health: Federal efforts need better planning and coordination. Washington, DC: U.S. Government Accountability Office,

Annotation: This report provides information on how federal agencies have addressed opioid use by pregnant women and neonatal abstinence syndrome (NAS). Topics include federally funded research, federal programs, and other federal agency efforts related to prenatal opioid use or NAS; gaps identified by federal agency officials and experts in efforts to address prenatal opioid use or NAS; and how federal efforts to address prenatal opioid use or NAS are planned and coordinated.

Contact: U.S. Government Accountability Office, 441 G Street, N.W., Washington, DC 20548, Telephone: (202) 512-3000 Secondary Telephone: E-mail: [email protected] Web Site: http://www.gao.gov Available from the website.

Keywords: Analgesic drugs, Federal agencies, Infant health, Newborn infants, Prenatal influences, Prevention, Program coordination, Program development, Program planning, Referrals, Research, Screening, Substance use

Partnership for Drug-Free Kids. 2015. Marijuana talk kit: What you need to know to talk with your teen about marijuana. New York, NY: Partnership for Drug-Free Kids, 20 pp.

Annotation: This toolkit is designed to help parents talk to adolescents about marijuana. Contents include facts about marijuana and why it is risky for adolescents, ways to talk with adolescents about marijuana including what to say and what not to say, how to respond to adolescents' questions and arguments, and resources to help.

Contact: Partnership for Drug-Free Kids, 352 Park Avenue South, 9th Floor, New York, NY 10010, Telephone: (855) 378-4373 Secondary Telephone: (212) 922-1560 Fax: (212) 922-1570 E-mail: [email protected] Web Site: http://www.drugfree.org/ Available from the website.

Keywords: Adolescents, Communication, Drug use behavior, Marijuana, Parents, Risk factors

Levi J, Segal LM, De Biasi A, Martin A. 2015. Reducing teen substance misuse: What really works. Washington, DC: Trust for America's Health, 99 pp.

Annotation: This report includes state-by-state youth drug overdose death rates and rankings, and a report card for how well states scored on 10 key indicators of leading evidence-based policies and programs that can improve the wellbeing of children and youth and have been connected with preventing and reducing misuse of alcohol, tobacco or other drugs.

Contact: Trust for America's Health, 1730 M Street, N.W., Suite 900, Washington, DC 20036, Telephone: (202) 223-9870 Fax: (202) 223-9871 E-mail: [email protected] Web Site: http://healthyamericans.org Available from the website.

Keywords: Adolescents, Alcohol consumption attitudes, Alcohol consumption behavior, Children, Drug use attitudes, Drug use behavior, Health education, Health policy, Prevention programs, Protective factors, Risk factors, Smoking, Tobacco use, Young adults

National Institute for Health Care Management Foundation. 2015. Reducing neonatal abstinence syndrome in Tennessee. Washington, DC: National Institute for Health Care Management Foundation, 2 pp. (Women, children & adolescents)

Annotation: This fact sheet highlights partnerships to address the neonatal abstinence syndrome (NAS) epidemic in Tennessee. Topics include efforts to expand a community-based program to assist mothers with substance abuse problems and ensure a drug-free and safe home for their newborns; provide start-up costs for a regional detox center for women addicted to prescription drugs; research the effectiveness of detox from opiate drugs during pregnancy, and the long-term effect of detox treatment on NAS rates in the state; and establish a hospital-based NAS treatment process.

Contact: National Institute for Health Care Management Foundation, 1225 19th Street, N.W., Suite 710, Washington, DC 20036, Telephone: (202) 296-4426 Fax: (202) 296-4319 E-mail: http://www.nihcm.org/contact Web Site: http://www.nihcm.org Available from the website.

Keywords: Drug addiction, Drug use during pregnancy, Financing, Neonatal abstinence syndrome, Newborn infants, Opiates, Postpartum care, Pregnant women, Prenatal care, Prevention program, State initiatives, Substance abuse treatment, Tennessee

University of Washington Health Sciences Administration, Alcohol and Drug Abuse Institute, Fetal Alcohol and Drug Unit. 2015. The Parent-Child Assistance Program (PCAP): Prevention & intervention with high-risk mothers and their children. Seattle, WA: Washington State Department of Social and Health Services, Division of Behavioral Health and Recovery, 6 pp.

Annotation: This brochure describes a program to prevent and/or reduce the risk of maternal alcohol and drug abuse by providing home visitation and intervention over a 3-year period by trained and supervised case managers. Contents include a description of the program goals, approach, client outcomes, and eligibility criteria. Topics include helping mothers build and maintain healthy independent family lives, assuring that children are in safe and stable homes, and preventing future births of alcohol and drug-exposed children.

Contact: University of Washington Health Sciences Administration, Alcohol and Drug Abuse Institute, Fetal Alcohol and Drug Unit, 180 Nickerson Street, Suite 309, Seattle, WA 98109, Telephone: (206) 543-7155 Fax: (206) 685-2903 Contact E-mail: [email protected] Web Site: http://depts.washington.edu/fadu Available from the website.

Keywords: Alcohol abuse, Alcohol use during pregnancy, Case management, Child safety, Drug abuse, Family support programs, Fetal alcohol effects, High risk children, High risk mothers, Home visiting, Postpartum care, Pregnancy, Pregnant women, Prenatal care, Program descriptions, Referrals, Risk factors, Substance abuse prevention programs, Substance abuse treatment services, Washington, Women

U.S. Preventive Services Task Force. 2014. Drug use, illicit: Primary care interventions for children and adolescents. Rockville, MD: U.S. Preventive Services Task Force, multiple items.

Lorenzo SB. 2014. Tobacco, alcohol, and substance use during preconception and pregnancy: Professional resource brief (upd. ed.). Washington, DC: National Center for Education in Maternal and Child Health, 1 p.

Romito L, Mandiwala R. 2014. Tobacco cessation toolkit for Indiana dental practices. Indianapolis, IN: Indiana Dental Association, 93 pp.

Annotation: This toolkit provides information on how oral health professionals can develop a tobacco-cessation-intervention program and outlines key roles for each member of the oral health team. Contents include information about tobacco use and prevalence, risks of tobacco use, secondhand smoke, benefits of cessation, nicotine and the physiology of dependence, tobacco-cessation counseling, pharmacotherapy, insurance coverage and coding, the role of dentists and the dental team, barriers and solutions, and resources.

Contact: Indiana Dental Association, 1319 East Stop 10 Road, Indianapolis, IN 46227, Telephone: (317) 634-2610 Secondary Telephone: (800) 562-5646 Fax: (317) 634-2612 E-mail: [email protected] Web Site: http://www.indental.org/ Available from the website.

Keywords: Adverse effects, Barriers, Counseling, Dental care, Drug dependence, Health insurance, Indiana, Intervention, Nicotine, Oral health, Program development, Reimbursement, Role, Smoking cessation, State programs, Tobacco use

American Dental Association. 2014. Summary of policy and recommendations regarding tobacco: 1964–present. Chicago, IL: American Dental Association, multiple items.

Annotation: This resource summarizes the American Dental Association's policy and recommendations related to tobacco use. Topics include tobacco cessation, tobacco and harm reduction, sources of tobacco-use-prevention and -cessation materials, and tobacco-free schools. The list shows the original adoption date for each policy and recommendation, and revision dates as applicable.

Contact: American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611-2678, Telephone: (312) 440-2500 Fax: (312) 440-7494 E-mail: [email protected] Web Site: http://www.ada.org Available from the website.

Keywords: Drug addiction, Intervention, Nicotine, Oral health, Resources for professionals, Smokeless tobacco, Smoking cessation, Tobacco use

Washington State Department of Health, Health Education Resource Exchange. 2013. Guidelines for testing and reporting drug exposed newborns in Washington state. Olympia, WA: Washington State Department of Health, Health Education Resource Exchange, 16 pp.

Annotation: This document provides guidance to hospitals, health care providers and affiliated professionals about maternal drug screening, laboratory testing, and reporting of drug-exposed newborns delivered in Washington State. Contents include indicators for testing, hospital policy, newborn and maternal risk indicators, consent issues for testing, newborn drug testing, management of a newborn with positive drug toxicology, and reporting to Children's Administration. Appendices include references and resources, guidelines for obtaining consent, a sample letter, neonatal abstinence syndrome scoring system, and information on Washington's Children's Administration prenatal substance abuse policy.

Contact: Washington State Department of Health, P.O. Box 47890, Olympia, WA 98504-7890, Telephone: (800) 525-0127 Secondary Telephone: (360) 236-4030 Web Site: http://www.doh.wa.gov Available from the website.

Keywords: Drug use during pregnancy, Guidelines, Hospital services, Infant health, Neonatal abstinence syndrome, Neonatal screening, Newborn infants, State initiatives, State social service agencies, Substance abusing pregnant women, Substance use screening, Washington

Delta Dental; Wisconsin Dental Association; and University of Wisconsin, Center for Tobacco Research and Intervention. 2013. Treating tobacco use and dependence: A toolkit for dental office teams. Madison, WI: University of Wisconsin, Center for Tobacco Research and Intervention, 73 pp.

Annotation: This toolkit for dental office staff focuses on integrating the U.S. Public Health Service recommended clinical practice guideline for treating tobacco use and dependence into standard office procedures. Contents include resources for implementing a brief intervention to help individuals who use tobacco quit. Topics include perceived barriers to tobacco treatment; tobacco dependence treatment roles for dental hygienists, dental assistants, and receptionists; medication resource materials for clinicians; consumer-education materials; and clinician reference materials.

Contact: University of Wisconsin, Center for Tobacco Research & Intervention, 1930 Monroe, Suite 200, Madison, WI 53711, Telephone: (608) 262-8673 Fax: (608) 265-3102 Web Site: http://www.ctri.wisc.edu Available from the website.

Keywords: Adolescents, Drug addiction, Guidelines, Intervention, Model programs, Oral health, Pregnant women, Preventive health services, Reimbursement, Resources for professionals, Smoking cessation, Tobacco use, Wisconsin

U.S. Office of the Surgeon General. 2012. Preventing tobacco use among youth and young adults: A report of the Surgeon General. Rockville, MD: U.S. Office of the Surgeon General, 899 pp., exec. summ. (11 pp.).

Annotation: This report provides information about the scientific evidence on smoking among adolescents and young adults. Topics include research on diseases caused by early tobacco use, the addiction process, epidemiology, risk factors, the tobacco industry’s influence, and prevention. An executive summary, consumer booklet, fact sheet, parent and physician conversation cards, public service announcements, and promotional buttons and e-cards are also available. The consumer booklet and fact sheet are available in English and Spanish.

Contact: U.S. Office of the Surgeon General, Tower Building, Plaza Level 1, Room 100, 1101 Wootton Parkway, Rockville, MD 20852, Telephone: (240) 276-8853 Fax: (240) 453-6141 Web Site: http://www.surgeongeneral.gov/index.html Available from the website.

Keywords: Adolescents, Chronic illnesses and disabilities, Drug addiction, Epidemiology, Health behavior, Marketing, Prevention, Risk factors, Smoking, Spanish language materials, Statistical data, Tobacco use, Young adults
    Next Page »

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.